Yet, Indias strengths30% lower manufacturing costs (The Hindu, 2024) and Section 107A Bolar exemptions for R&D (Cyril Amarchand, 2024)position it to lead post-2026 generics, as Biocons liraglutide approval shows (Aranca, 2025)
Combined with positive testimonials, they are emerging as tools worth exploring under professional supervision
Fourteen of sixteen patients (87.5%) experienced significant pain relief
Integrative analysis of gut microbiome and host transcriptome reveal novel molecular signatures in Hashimotos thyroiditis
Mitochondria in salivary glandular epithelial cells show an abnormal structure with increased lymphocyte infiltration
Instead of blocking the signaling proteins, bima works by blocking the receptor for myostatin, activin A, and other body-composition regulating signals